CHESTER, N.J., May 1 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. is scheduled to announce its sales and earnings results for the fiscal third quarter of 2006 on Thursday, May 11, 2006, before the market opens. At 9:00 a.m. (EDT) on that day, Adams will conduct a conference call to review the fiscal third quarter results. Michael J. Valentino, president and CEO, and David P. Becker, executive vice president, CFO and Treasurer, will host the conference call.
To listen live to the call, dial 1-877-669-8882 or 1-706-758-9391. A replay of the call will be available starting at approximately 12 p.m. on May 11 through 5 p.m. on May 18. To listen to the replay, dial 1-800-642-1687 or 1-706-645-9291 and enter the conference ID# 8412031.
A live audio webcast of the conference call also will be available by going to the Investor Relations section of the Adams web site, http://www.adamsrt.com. A replay of the webcast will be available starting at approximately 11 a.m. on May 11 through 5 p.m. on June 12.
About Adams Respiratory Therapeutics, Inc.
Adams is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.
Adams Respiratory Therapeutics, Inc.CONTACT: Janet M. Barth of Adams Respiratory Therapeutics, Inc.,+1-908-879-2428
Web site: http://www.adamsrt.com/
